Cargando…
P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429838/ http://dx.doi.org/10.1097/01.HS9.0000972932.76052.0f |
| _version_ | 1785090811741863936 |
|---|---|
| author | Callegari, Chiara Mutti, Martina Soravia, Alessandra Lauzzana, Pietro Lazzarotto, Davide Peghin, Maddalena Cordella, Stefano Fanin, Renato Candoni, Anna |
| author_facet | Callegari, Chiara Mutti, Martina Soravia, Alessandra Lauzzana, Pietro Lazzarotto, Davide Peghin, Maddalena Cordella, Stefano Fanin, Renato Candoni, Anna |
| author_sort | Callegari, Chiara |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429838 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104298382023-08-17 P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. Callegari, Chiara Mutti, Martina Soravia, Alessandra Lauzzana, Pietro Lazzarotto, Davide Peghin, Maddalena Cordella, Stefano Fanin, Renato Candoni, Anna Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429838/ http://dx.doi.org/10.1097/01.HS9.0000972932.76052.0f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Callegari, Chiara Mutti, Martina Soravia, Alessandra Lauzzana, Pietro Lazzarotto, Davide Peghin, Maddalena Cordella, Stefano Fanin, Renato Candoni, Anna P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title | P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title_full | P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title_fullStr | P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title_full_unstemmed | P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title_short | P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION. |
| title_sort | p1513: reduction of the prophylactic effect of tixagevimab-cilgavimab in the omicron era in patients with hematological malignancies and without antibody response following sars-cov-2 vaccination. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429838/ http://dx.doi.org/10.1097/01.HS9.0000972932.76052.0f |
| work_keys_str_mv | AT callegarichiara p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT muttimartina p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT soraviaalessandra p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT lauzzanapietro p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT lazzarottodavide p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT peghinmaddalena p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT cordellastefano p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT faninrenato p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination AT candonianna p1513reductionoftheprophylacticeffectoftixagevimabcilgavimabintheomicronerainpatientswithhematologicalmalignanciesandwithoutantibodyresponsefollowingsarscov2vaccination |